PLOD1 and hyperandrogenism: We expect an improvement of biochemical hyperandrogenism and HPG axis imbalance, a decrease of androstenedione and sex-hormone-binding globulin, besides the expected decrease in the levels of LH, LH/FSH ratio, total testosterone, estradiol, and on the scoring of the modified Ferriman–Gallwey and Ludwig scales.